期刊文献+

2023年度胰腺外科治疗进展及焦点展望

Progress of pancreatic surgical treatment in 2023
原文传递
导出
摘要 胰腺外科是普通外科领域内最具挑战性的专科。由于胰腺外科疾病种类多,手术难度高,不同病种间诊疗思路存在差异,仍有许多争议亟待解决。本文从胰腺炎、胰腺囊性疾病、胰腺神经内分泌肿瘤、胰腺癌的外科治疗,以及新辅助治疗、辅助治疗、免疫及靶向治疗等方面,对2023年胰腺外科临床与转化研究的前沿进展进行归纳与梳理,以期进一步规范胰腺外科诊治。 Pancreatic surgery is one of the most challenging specialties in general surgery.Due to the variety of pancreatic diseases,the difficulty of surgery,and the differences in diagnosis and treatment among different diseases,treatment strategies for these diseases remain controversial.From the aspects of surgical treatment such as pancreatitis,pancreatic cystic neoplasms,pancreatic neuroendocrine neoplasms,and pancreatic cancer,as well as neoadjuvant therapy,adjuvant therapy,immunotherapy,and targeted therapy.We review and summarize the frontier progress of clinical and translational research in pancreatic surgery in 2023,in order to further standardize the diagnosis and treatment of pancreatic surgery.
作者 王若冰 刘悦泽 张太平 Wang Ruobing;Liu Yueze;Zhang Taiping(Department of General Surgery,Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100730,China)
出处 《中华普通外科杂志》 CSCD 北大核心 2024年第1期14-18,共5页 Chinese Journal of General Surgery
基金 国家自然科学基金(82272917)。
关键词 胰腺炎 胰腺肿瘤 手术治疗 新辅助治疗 进展 Pancreatitis Pancreatic neoplasms Surgical treatment Neoadjuvant therapy Progress
  • 相关文献

参考文献2

二级参考文献14

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部